<h1 itemprop="aspect"> <strong>Synagis Side Effects</strong></h1><div class="thumbnail-div"> <img width="84" height="84" src="http://www.bad-drug.net/wp-content/uploads/2012/05/84x84xsynagis-84x84.jpg,q1df917.pagespeed.ic.rPs06BkZS0.jpg" class="attachment-84x84 wp-post-image" alt="Synagis" title="Synagis"/></div> Synagis | palivizmab side effects and adverse reactions include:<ul><li>irritation at injection site</li><li>flu-like symptoms</li><li>fever</li><li>achiness</li><li>cough</li><li>swelling</li><li>nausea or upset stomach</li><li>crying in infants</li></ul> Very rarely, Synagis | palivizumab may cause severe allergic reaction. If the treated individual experiences the following symptoms, seek treatment immediately:<ul><li>hives</li><li>itchiness</li><li>trouble breathing</li><li>hoarseness</li><li>ear pain or discharge</li><li>palpitations</li><li>fever</li><li>chest tightness</li><li>muscle weakness</li><li>swelling of the lips, face, or tongue</li></ul> Tell us about your side effects and adverse reactions by filling out our <a href="http://www.bad-drug.net/report-a-bad-drug">report-a-bad-drug</a> form.&nbsp;</div><div class="v" id="tab2" ><h2 itemprop="aspect"> <strong> Warnings & Recalls for Synagis </strong></h2> Synagis can only be given as an intramuscular injection. As with other intramuscular injections, use Synagis with caution in individuals who have a history of or predisposition to blood clots, coagulation problems, or <a href="http://www.mayoclinic.com/health/thrombocytopenia/DS00691">thrombocytopenia</a>.In 2002 the FDA sent Med Immune, Inc. a safety alert for medical products citing a change to the prescribing information that included an increased risk of <a href="http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001847/">anaphylaxis</a>, or severe allergic reaction.</div><div class="v" id="tab3" ><h2 itemprop="aspect"> <strong> Synagis Treatment and Use </strong></h2><div class="thumbnail-div"> <img width="84" height="84" src="http://www.bad-drug.net/wp-content/uploads/2012/05/84x84xsynagis-84x84.jpg,q1df917.pagespeed.ic.rPs06BkZS0.jpg" class="attachment-84x84 wp-post-image" alt="Synagis" title="Synagis"/></div><p>Synagis | palivizumab, manufactured by MedImmune, Inc. is a <a target="_blank" href="http://en.wikipedia.org/wiki/Monoclonal_antibodies">monoclonal antibody</a> used to prevent human respiratory syncytial virus (<a target="_blank" href="http://www.cdc.gov/rsv/">RSV</a>), a virus that causes different types of respiratory tract infections. Synagis is primarily used on children and elderly individuals with pre-existing heart and lung conditions.</p><p>It is important to note that Synagis is only to be used for RSV prevention and will not treat an existing RSV infection.</p><h2>How does Synagis work?</h2><p>Synagis gives the treated individual a certain amount of anti-bodies that help to prevent occurrances of RSV during RSV season.</p><h2>Synagis dosing</h2><p>Synagis comes as a clear or mildly opalescent solution to be administered via an intramuscular injection shortly before the start of RSV season and once monthly through the duration.</p><h2></h2></div><div class="v" id="tab4" ><h2 itemprop="aspect"> Other Names for Synagis</h2> Brand name:<br/><ul><br/><li>Synagis | palivizumab</li><br/></ul></div><div class="v" id="tab5" ><h2 itemprop="aspect"> <strong> Lawsuits & Legal Information for Synagis </strong></h2>